This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
The authors would like to thank J. Karlawish, B. Hyman, M. Albers and A. Sarpatwari for their comments on an earlier draft.
Since submission of this manuscript, T.J.H. has been employed by Bain Capital, which has invested in health care companies but had no involvement in the study. The authors' funders, grantors and employers had no role in the design and conduct of the study; collection, management, analysis and intepretation of the data; preparation, review and approval of the manuscript; and decision to submit the manuscript for publication.
About this article
Cite this article
Kesselheim, A., Hwang, T. & Franklin, J. Two decades of new drug development for central nervous system disorders. Nat Rev Drug Discov 14, 815–816 (2015). https://doi.org/10.1038/nrd4793